These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure. Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067 [TBL] [Abstract][Full Text] [Related]
46. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [TBL] [Abstract][Full Text] [Related]
47. NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC. Gao P; Qian DH; Li W; Huang L Mol Cell Biochem; 2009 Apr; 324(1-2):165-72. PubMed ID: 19104909 [TBL] [Abstract][Full Text] [Related]
48. Cardiovascular-related peptides influence hypothalamic neurons involved in control of body water homeostasis. Yamamoto S; Inenaga K; Eto S; Yamashita H Obes Res; 1995 Dec; 3 Suppl 5():789S-794S. PubMed ID: 8653564 [TBL] [Abstract][Full Text] [Related]
49. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells. Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572 [TBL] [Abstract][Full Text] [Related]
50. Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria. Choate JK; Paterson DJ J Auton Nerv Syst; 1999 Feb; 75(2-3):100-8. PubMed ID: 10189110 [TBL] [Abstract][Full Text] [Related]
51. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta. Zhou HL; Fiscus RR Neuropeptides; 1989 Oct; 14(3):161-9. PubMed ID: 2559355 [TBL] [Abstract][Full Text] [Related]
52. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Woods RL Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):791-4. PubMed ID: 15566395 [TBL] [Abstract][Full Text] [Related]
53. Functional evidence for an active role of B-type natriuretic peptide in cardiac remodelling and pro-arrhythmogenicity. Thireau J; Karam S; Fauconnier J; Roberge S; Cassan C; Cazorla O; Aimond F; Lacampagne A; Babuty D; Richard S Cardiovasc Res; 2012 Jul; 95(1):59-68. PubMed ID: 22617407 [TBL] [Abstract][Full Text] [Related]
54. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244 [TBL] [Abstract][Full Text] [Related]
55. Effects of natriuretic peptides (ANP, BNP, CNP) on catecholamine synthesis and TH mRNA levels in PC12 cells. Takekoshi K; Ishii K; Isobe K; Nomura F; Nammoku T; Nakai T Life Sci; 2000 Apr; 66(22):PL303-11. PubMed ID: 10834306 [TBL] [Abstract][Full Text] [Related]
56. BNP-induced activation of cGMP in human cardiac fibroblasts: interactions with fibronectin and natriuretic peptide receptors. Huntley BK; Sandberg SM; Noser JA; Cataliotti A; Redfield MM; Matsuda Y; Burnett JC J Cell Physiol; 2006 Dec; 209(3):943-9. PubMed ID: 16986166 [TBL] [Abstract][Full Text] [Related]
57. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides. Ronkainen JJ; Vuolteenaho O; Tavi P Endocrinology; 2007 Jun; 148(6):2815-20. PubMed ID: 17332063 [TBL] [Abstract][Full Text] [Related]
58. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Hamad AM; Range S; Holland E; Knox AJ Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856 [TBL] [Abstract][Full Text] [Related]
59. PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts. Meier S; Andressen KW; Aronsen JM; Sjaastad I; Hougen K; Skomedal T; Osnes JB; Qvigstad E; Levy FO; Moltzau LR Eur J Pharmacol; 2017 Oct; 812():174-183. PubMed ID: 28697992 [TBL] [Abstract][Full Text] [Related]
60. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Pierkes M; Gambaryan S; Bokník P; Lohmann SM; Schmitz W; Potthast R; Holtwick R; Kuhn M Cardiovasc Res; 2002 Mar; 53(4):852-61. PubMed ID: 11922895 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]